Catalyst Wire Dossier Catalyst Wire Dossier

ALCAFTADINE

ALCAFTADINE · Alembic Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ALCAFTADINE, covering 2023-06-23 to 2024-10-02. Get the full timeline:

Most recent: FDA Approved: ALCAFTADINE — Original Application (Alembic Pharmaceuticals Inc.)

See pricing